Tuberculosis Prevention in Pregnant Women Living with HIV: A Review of the Current Management Strategies and Guidance
Abstract
Introduction: Tuberculosis (TB) is a leading cause of maternal mortality globally, especially for women living with HIV. TB preventive therapy (TPT) regimens treat TB infection and prevent progression to TB disease, but the components of these regimens, including isoniazid and rifamycins, often interact with HIV antiretroviral therapy (ART). There are limited data on drug-drug interactions, adverse pregnancy outcomes, and treatment success specifically in pregnant women living with HIV on ART but several new trials in pregnancy have recently been conducted.
Objective: To perform a comprehensive narrative review of the literature outlining the available updated guidance and pregnancy considerations for implementing TPT in pregnant women living with HIV.
Methods: We performed a narrative review to explore an in-depth yet flexible overview of TPT in pregnancy. Keywords related to pregnant women living with HIV on ART and TPT were used to identify manuscripts in PubMed from 1980 to 2026. All primary literature including various study designs was included; review manuscripts were excluded.
Results: Three hundred and sixty-nine initial results were screened for relevance. Two hundred and seventy-seven abstracts were then chosen, and ultimately 111 manuscripts were extracted. These manuscripts and their reference lists were reviewed, and ultimately 78 references published from 1980 to 2026 were included for our review. We included six randomized controlled trials, 17 references…
Read the paper
Related studies
- Ferulic acid regulates the AKT/GSK-3β/CRMP-2 signaling pathway in a middle cerebral artery occlusion animal model
- Novel Pharmacokinetic/Pharmacodynamic Parameters Quantify the Exposure–Effect Relationship of Levofloxacin against Fluoroquinolone-Resistant Escherichia coli
- Photochemical behavior of levofloxacin
- Correlation Between Dissolution Profiles of Salt-Form Drugs in Biorelevant Bicarbonate Buffer and Oral Drug Absorption: Importance of Dose/ Fluid Volume Ratio
- Evaluation of the synergistic potential and mechanisms of action for de novo designed cationic antimicrobial peptides
- Synthesis of [11C]levofloxacin
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.